Titan, Silvia M.
Laureati, Paola
Sang, Yingying
Chang, Alex R.
Evans, Marie
Trevisan, Marco
Levey, Andrew S.
Grams, Morgan E.
Inker, Lesley A.
Carrero, Juan-Jesus
Article History
Received: 24 October 2019
Accepted: 3 February 2020
First Online: 9 May 2020
Compliance with ethical standards
:
: Dr. Evans reports funding to Karolinska Institutet from Astra Zeneca and Astellas outside this work and payment for lectures (Astellas, Vifor Pharma) and advisory board (Astra Zeneca, Astellas). Dr. Grams reports funding from the National Kidney Foundation and the NIH. Dr. Inker reports funding to Tufts Medical Center for research and contracts with the NIH, NKF, Dialysis Inc., Retrophin, Omeros, and Reata Pharmaceuticals. She has consulting agreements with Tricida. Dr. Carrero reports funding to Karolinska Institutet for research from AstraZeneca, Viforpharma, Astellas, and MSD outside the submitted work. He has performed consultation for Fresenius and Baxter. All the other authors declare that they have no conflict of interest